Cardiovascular risk profile

There are 2 papers on cardiovascular risk profile in aging research: 2 observational studies in people. The newest story, Oct 27, 2026: “Women showed two patterns of hormone decline near menopause”.

Biomarker

2 papers study it130 more mention it2 findings

25 new papers in 30 daysSee all 132

“lower cardiovascular risk profile was associated with reduced 20-year all-cause mortality in both genders, with stronger results for women (HR = 0.42 [95%CI:0.25-0.69]”
Cardiovascular risk profiles and 20-year mortality in older people: gender differences in the Pro.V.A. studyEuropean journal of ageing2021doi:10.1007/s10433-021-00620-y
  • Humans2

Associations

2

Cardiovascular disease mortality

downin humans1

1 study
  1. Cardiovascular risk profile is linked with a lower risk of cardiovascular disease mortality in humans.

    “This trend was more marked for CVD mortality.”

    Humans20 years

    Cardiovascular risk profiles and 20-year mortality in older people: gender differences in the Pro.V.A. study

    European journal of ageing

Mortality

downin humans1HR 0.42

1 study
  1. Cardiovascular risk profile is linked with a lower risk of mortality in humans (HR = 0.42 [95%CI:0.25-0.69]).

    “lower cardiovascular risk profile was associated with reduced 20-year all-cause mortality in both genders, with stronger results for women (HR = 0.42 [95%CI:0.25-0.69]”

    Humans20 yearsfemales

    Cardiovascular risk profiles and 20-year mortality in older people: gender differences in the Pro.V.A. study

    European journal of ageing

Latest

Nov 2025: 2Dec 2025: 4Jan 2026: 5Feb 2026: 2Mar 2026: 6Apr 2026: 1May 2026: 3Jun 2026: 5Jul 2026: 2Aug 2026: 8Sep 2026: 7Oct 2026: 2267 papers in 12 months
Obstetrics and Gynecology

Women showed two patterns of hormone decline near menopause

Median hormone decline was 1.2 versus 6.7 picograms per milliliter per month in women with lower versus higher starting levels.Median hormone decline was 1.2 versus 6.7 picograms per milliliter per month in women with lower versus higher starting levels.

Cohort · 1,131 peopleMenopause
ESC Congress 2026 Abstract

Continuing hormones after heart attack not linked to added 1-year risk

The adjusted relative event rate was 1.11 for continuing versus stopping hormone therapy at one year; the range of likely values included no difference.The adjusted relative event rate was 1.11 for continuing versus stopping hormone therapy at one year; the range of likely values included no difference.

Cohort · 1,818 peopleMyocardial infarction
ESC Congress 2026 Abstract

Heart defects linked to more complications in artery disease

An observational study of 35,064 adults born with heart defects and diagnosed with artery disease found more complications despite fewer conventional risk factors.An observational study of 35,064 adults born with heart defects and diagnosed with artery disease found more complications despite fewer conventional risk factors.

Cohort · 35,064 peoplePopulations
ESC Congress 2026 Abstract

Sleep apnea measures linked to cardiovascular death in adults

Among 4,790 adults, those with high oxygen-drop burden and large heart rate surges had a 9.20% risk of cardiovascular death over 10 years.Among 4,790 adults, those with high oxygen-drop burden and large heart rate surges had a 9.20% risk of cardiovascular death over 10 years.

Cohort · 4,790 peopleCardiovascular disease

See all 132